CD274 and dermatitis: In this way, PD-1 inhibitors can enhance immune responses through both the PD-1–PD-L1 and PD-1–PD-L2 axes, which may lead to skin inflammations driven by various types of Th1, Th2, and Th17 cytokines [31,32,33,34,35,36].